- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/595 - GastrinsCholecystokinins [CCK]
Patent holdings for IPC class C07K 14/595
Total number of patents in this class: 28
10-year publication summary
|
3
|
3
|
2
|
3
|
2
|
1
|
0
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Zealand Pharma A/S | 241 |
5 |
| Paul Scherrer Institut | 298 |
4 |
| Waratah Pharmaceuticals Inc. | 18 |
2 |
| Novo Nordisk A/S | 2273 |
2 |
| OncoQR ML GmbH | 4 |
2 |
| Board of Regents, The University of Texas System | 5641 |
1 |
| Adda Biotech Inc. | 6 |
1 |
| Cancer Advances, Inc. | 16 |
1 |
| City of Hope | 963 |
1 |
| Compagnie des Peches Saint Malo Sante | 5 |
1 |
| Eli Lilly and Company | 3733 |
1 |
| Museum National D'histoire Naturelle | 39 |
1 |
| OnkoLogix Ltd | 4 |
1 |
| Provincial Health Services Authority | 167 |
1 |
| Public University Corporation Yokohama City University | 231 |
1 |
| The University of British Columbia | 1468 |
1 |
| Ecs-progastrin SA | 8 |
1 |
| Astrimmune Limited | 1 |
1 |
| Other owners | 0 |